PMH16 COST-BENEFIT ANALYSIS OF FOUR ANTIPSYCHOTIC DRUGS FOR THE TREATMENT OF SCHIZOPHRENIA IN COLOMBIA
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73937-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)73937-1/fulltext
Section Title :
Section Order :
419
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73937-1&doi=10.1016/S1098-3015(10)73937-1